421 related articles for article (PubMed ID: 31196369)
1. [New Advances in the Treatment for Small Cell Lung Cancer].
Cui X; Song P; Zhang L
Zhongguo Fei Ai Za Zhi; 2019 Jun; 22(6):355-362. PubMed ID: 31196369
[TBL] [Abstract][Full Text] [Related]
2. [Clinical Research Progress of Immune Checkpoint Inhibitors in the Treatment of
Small Cell Lung Cancer].
Huang B; Duan Y
Zhongguo Fei Ai Za Zhi; 2019 Apr; 22(4):239-244. PubMed ID: 31014443
[TBL] [Abstract][Full Text] [Related]
3. [Clinical Trial Progress and Application of Immune Checkpoint Inhibitors
in the Treatment of Small Cell Lung Cancer].
Zhang H; Li X; Li X; Su Y
Zhongguo Fei Ai Za Zhi; 2021 Nov; 24(11):790-795. PubMed ID: 34802211
[TBL] [Abstract][Full Text] [Related]
4. Extensive-stage small-cell lung cancer: Current management and future directions.
Yu Y; Chen K; Fan Y
Int J Cancer; 2023 Jun; 152(11):2243-2256. PubMed ID: 36346100
[TBL] [Abstract][Full Text] [Related]
5. Emerging drugs for small cell lung cancer: a focused review on immune checkpoint inhibitors.
Reddy HG; Qin A; Kalemkerian GP
Expert Opin Emerg Drugs; 2020 Sep; 25(3):353-366. PubMed ID: 32683991
[TBL] [Abstract][Full Text] [Related]
6. The efficiency and safety of immune checkpoint inhibitors in the treatment of small cell lung cancer: a meta-analysis.
Zhang S; Bi M
Ann Palliat Med; 2020 Nov; 9(6):4081-4088. PubMed ID: 33302668
[TBL] [Abstract][Full Text] [Related]
7. [Research progress of anti-angiogenic drugs in the treatment of small cell lung cancer].
Wang J; Li K
Zhonghua Zhong Liu Za Zhi; 2020 Aug; 42(8):624-628. PubMed ID: 32867452
[TBL] [Abstract][Full Text] [Related]
8. Personalized Therapy of Small Cell Lung Cancer.
Schneider BJ; Kalemkerian GP
Adv Exp Med Biol; 2016; 890():149-74. PubMed ID: 26703804
[TBL] [Abstract][Full Text] [Related]
9. Rationale for chemotherapy, immunotherapy, and checkpoint blockade in SCLC: beyond traditional treatment approaches.
Spigel DR; Socinski MA
J Thorac Oncol; 2013 May; 8(5):587-98. PubMed ID: 23546044
[TBL] [Abstract][Full Text] [Related]
10. Targeted Therapy and Immune Therapy for Small Cell Lung Cancer.
Gadgeel SM
Curr Treat Options Oncol; 2018 Sep; 19(11):53. PubMed ID: 30203184
[TBL] [Abstract][Full Text] [Related]
11. [Advances in the Treatment of Relapsed Small Cell Lung Cancer].
Liu B; Qin J; Zhou J
Zhongguo Fei Ai Za Zhi; 2017 Mar; 20(3):192-198. PubMed ID: 28302222
[TBL] [Abstract][Full Text] [Related]
12. Small cell lung cancer; recent advances of its biology and therapeutic perspective.
Hayashi R; Inomata M
Respir Investig; 2022 Mar; 60(2):197-204. PubMed ID: 34896039
[TBL] [Abstract][Full Text] [Related]
13. Novel Therapeutic Options for Small Cell Lung Cancer.
Canova S; Trevisan B; Abbate MI; Colonese F; Sala L; Baggi A; Bianchi SP; D'Agostino A; Cortinovis DL
Curr Oncol Rep; 2023 Nov; 25(11):1277-1294. PubMed ID: 37870696
[TBL] [Abstract][Full Text] [Related]
14. Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
Sharp A; Bhosle J; Abdelraouf F; Popat S; O'Brien M; Yap TA
Eur J Cancer; 2016 Jun; 60():26-39. PubMed ID: 27060747
[TBL] [Abstract][Full Text] [Related]
15. Advances in new targets for immunotherapy of small cell lung cancer.
Zheng Z; Liu J; Ma J; Kang R; Liu Z; Yu J
Thorac Cancer; 2024 Jan; 15(1):3-14. PubMed ID: 38093497
[TBL] [Abstract][Full Text] [Related]
16. Treatment of small cell lung cancer: recent advances.
Chu X; Han C; Su C
Curr Opin Oncol; 2022 Jan; 34(1):83-88. PubMed ID: 34698669
[TBL] [Abstract][Full Text] [Related]
17. [Highlights of PAPR Inhibitors in Small Cell Lung Cancer].
Zhang S; Liu J; Yang C; Zhang L; Li S; Bao H; Cheng Y
Zhongguo Fei Ai Za Zhi; 2020 Sep; 23(9):806-810. PubMed ID: 32752582
[TBL] [Abstract][Full Text] [Related]
18. The impact of angiogenesis inhibitors on survival of patients with small cell lung cancer.
Shi X; Dong X; Young S; Chen AM; Liu X; Zheng Z; Huang K; Lu D; Feng S; Morahan G; Cai K
Cancer Med; 2019 Oct; 8(13):5930-5938. PubMed ID: 31433125
[TBL] [Abstract][Full Text] [Related]
19. Current state of the art and future perspectives with immunotherapy in the management of small cell lung cancer.
Rijavec E; Genova C; Biello F; Rossi G; Indini A; Grossi F
Expert Rev Respir Med; 2021 Nov; 15(11):1427-1435. PubMed ID: 34590937
[TBL] [Abstract][Full Text] [Related]
20. Predictive biomarkers for immunotherapy response in extensive-stage SCLC.
Zhu L; Qin J
J Cancer Res Clin Oncol; 2024 Jan; 150(1):22. PubMed ID: 38245636
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
